Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Tolerance of high-intensity focused ultrasound ablation in patients with hepatocellular carcinoma.

Cheung TT, Chu FS, Jenkins CR, Tsang DS, Chok KS, Chan AC, Yau TC, Chan SC, Poon RT, Lo CM, Fan ST.

World J Surg. 2012 Oct;36(10):2420-7. doi: 10.1007/s00268-012-1660-7.

2.

Tolerance of radiofrequency ablation by patients of hepatocellular carcinoma.

Cheung TT, Ng KK, Poon RT, Fan ST.

J Hepatobiliary Pancreat Surg. 2009;16(5):655-60. doi: 10.1007/s00534-009-0103-9.

PMID:
19370304
3.

High-intensity focused ultrasound ablation: an effective bridging therapy for hepatocellular carcinoma patients.

Cheung TT, Fan ST, Chan SC, Chok KS, Chu FS, Jenkins CR, Lo RC, Fung JY, Chan AC, Sharr WW, Tsang SH, Dai WC, Poon RT, Lo CM.

World J Gastroenterol. 2013 May 28;19(20):3083-9. doi: 10.3748/wjg.v19.i20.3083.

4.

Survival analysis of high-intensity focused ultrasound ablation in patients with small hepatocellular carcinoma.

Cheung TT, Fan ST, Chu FS, Jenkins CR, Chok KS, Tsang SH, Dai WC, Chan AC, Chan SC, Yau TC, Poon RT, Lo CM.

HPB (Oxford). 2013 Aug;15(8):567-73. doi: 10.1111/hpb.12025.

5.

Radiofrequency ablation for the treatment of hepatocellular carcinoma with decompensated cirrhosis.

Wakuta A, Nouso K, Kariyama K, Nishimura M, Kishida M, Wada N, Mizushima T, Higashi T, Tanimoto M.

Oncology. 2011;81(1):39-44. doi: 10.1159/000331411.

PMID:
21912196
6.

Follow-up of high-intensity focused ultrasound treatment for patients with hepatocellular carcinoma.

Xu G, Luo G, He L, Li J, Shan H, Zhang R, Li Y, Gao X, Lin S, Wang G.

Ultrasound Med Biol. 2011 Dec;37(12):1993-9. doi: 10.1016/j.ultrasmedbio.2011.08.011.

PMID:
22036638
7.

Therapeutic effects and prognostic factors in high-intensity focused ultrasound combined with chemoembolisation for larger hepatocellular carcinoma.

Li C, Zhang W, Zhang R, Zhang L, Wu P, Zhang F.

Eur J Cancer. 2010 Sep;46(13):2513-21. doi: 10.1016/j.ejca.2010.06.015.

PMID:
20663659
8.

Pilot study of high-intensity focused ultrasound ablation as a bridging therapy for hepatocellular carcinoma patients wait-listed for liver transplantation.

Chok KS, Cheung TT, Lo RC, Chu FS, Tsang SH, Chan AC, Sharr WW, Fung JY, Dai WC, Chan SC, Fan ST, Lo CM.

Liver Transpl. 2014 Aug;20(8):912-21. doi: 10.1002/lt.23892.

9.

[Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].

Wu J, Chen MH, Yang W, Wu W, Yan K.

Zhonghua Gan Zang Bing Za Zhi. 2012 Apr;20(4):256-60. doi: 10.3760/cma.j.issn.1007-3418.2012.04.006. Chinese.

PMID:
22964144
10.

High intensity focused ultrasound (HIFU) therapy for local treatment of hepatocellular carcinoma: role of partial rib resection.

Zhu H, Zhou K, Zhang L, Jin C, Peng S, Yang W, Li K, Su H, Chen W, Bai J, Wu F, Wang Z.

Eur J Radiol. 2009 Oct;72(1):160-6. doi: 10.1016/j.ejrad.2008.07.003.

PMID:
18707834
11.

Radio frequency ablation for hepatocellular carcinoma in cirrhotic patients: prognostic factors for survival.

Guglielmi A, Ruzzenente A, Sandri M, Pachera S, Pedrazzani C, Tasselli S, Iacono C.

J Gastrointest Surg. 2007 Feb;11(2):143-9.

PMID:
17390163
12.

The role of living-donor liver transplantation in surgical treatment for hepatocellular carcinoma.

Yokoi H, Isaji S, Yamagiwa K, Tabata M, Nemoto A, Sakurai H, Usui M, Uemoto S.

J Hepatobiliary Pancreat Surg. 2006;13(2):123-30.

PMID:
16547673
13.

Radiofrequency ablation of hepatocellular carcinoma: long-term outcome and prognostic factors.

Yan K, Chen MH, Yang W, Wang YB, Gao W, Hao CY, Xing BC, Huang XF.

Eur J Radiol. 2008 Aug;67(2):336-47.

PMID:
17765421
14.

Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma.

Ng KK, Poon RT, Lo CM, Yuen J, Tso WK, Fan ST.

J Gastrointest Surg. 2008 Jan;12(1):183-91.

PMID:
17874276
15.

High-intensity focused ultrasound combined with transarterial chemoembolization for unresectable hepatocellular carcinoma: long-term follow-up and clinical analysis.

Jin C, Zhu H, Wang Z, Wu F, Chen W, Li K, Su H, Zhou K, Gong W.

Eur J Radiol. 2011 Dec;80(3):662-9. doi: 10.1016/j.ejrad.2010.08.042.

PMID:
20864286
16.

High-intensity focused ultrasound ablation induced apoptosis in human hepatocellular carcinoma.

Yi J, Wu L, Liu Z, Zou H, Li N, Chen H, Liu J, Li T, Zhang G.

Hepatogastroenterology. 2014 Nov-Dec;61(136):2336-9.

PMID:
25699378
17.

Surgical resection versus local ablation for HCC on cirrhosis: results from a propensity case-matched study.

Ruzzenente A, Guglielmi A, Sandri M, Campagnaro T, Valdegamberi A, Conci S, Bagante F, Turcato G, D'Onofrio M, Iacono C.

J Gastrointest Surg. 2012 Feb;16(2):301-11; discussion 311. doi: 10.1007/s11605-011-1745-x.

PMID:
22095524
18.

Intraoperative and percutaneous radiofrequency thermal ablation in the treatment of hepatocellular carcinoma.

Nicoli N, Casaril A, Marchiori L, Mangiante G, Marini G, Colombari R, Portuese A, Hasheminia AR.

Chir Ital. 2000 Jan-Feb;52(1):29-40.

PMID:
10832524
19.

High-intensity focused ultrasound ablation of thyroid nodules: first human feasibility study.

Esnault O, Franc B, Ménégaux F, Rouxel A, De Kerviler E, Bourrier P, Lacoste F, Chapelon JY, Leenhardt L.

Thyroid. 2011 Sep;21(9):965-73. doi: 10.1089/thy.2011.0141.

PMID:
21834683
20.

High intensity focused ultrasound, liver disease and bridging therapy.

Mearini L.

World J Gastroenterol. 2013 Nov 21;19(43):7494-9. doi: 10.3748/wjg.v19.i43.7494. Review.

Supplemental Content

Support Center